uveitic


Also found in: Dictionary, Thesaurus, Encyclopedia.

u·ve·it·ic

(yū'vē-it'ik),
Relating to the uvea.
Farlex Partner Medical Dictionary © Farlex 2012

u·ve·it·ic

(yū'vē-it'ik)
Relating to the uvea.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

uveitic

(ū-vē-ĭt′ĭk) [″ + Gr. itis, inflammation]
Marked by or pert. to uveitis.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
"Intravitreal triamcinolone acetonide and the IDI were superior to PTA for treating uveitic ME with modest increases in the risk of intraocular pressure elevation," the authors write.
One patient had uveitic membrane in the early postoperative period, which resolved after two months (Fig.
Opportunities for suprachoroidal delivery were recently featured in several professional journals including two articles in the official journal of the ASRS, Retina Times: 'Suprachoroidal Drug Delivery for Uveitic Macular Edema'; 'Gene Therapy: Predicting the Impact on Treating Rare and Chronic Diseases' and a feature article in Ophthalmology Management titled 'Introduction to Gene Therapy.'
It is critically important to decrease uveitic recurrences to prevent blindness associated with secondary effects of inflammation," said Dr.
However, a bilateral effect following unilateral anti-VEGF injection has been reported previously in some patients with neovascular AMD [3-5], DME [6-10], and uveitic cystoid macular edema [14].
Uveitic glaucoma and neovascular glaucoma were excluded in the subgroup analysis because only phacoTbx was performed for those cases in our series.
[4] Many ocular diseases including diabetic retinopathy, vascular occlusions, postsurgical conditions and uveitic diseases lead to the development of macular oedema.
Other studies confirmed that HSM PMMA have good uveal biocompatibility in uveitic patients.
Therapeutically qualified optometrists in practice are now able to reinstate uveitic therapy for second and subsequent episodes of acute anterior recurrent uveitis, with routine referral at the third episode for medical investigations.
[39] reported fluctuations in the apoptosis level of PMNs in accord with uveitic activity in BD patients and attributed this to impairment of the FasL-Fas interaction, which the authors suggested might explain the alternation between sudden inflammation attacks and self-limiting resolution in BU.
They discuss conjunctival symblepharon therapy; the management of uveitic glaucoma; corneal procedures; cataract extraction and intraocular lens placement; various types of biopsies; therapeutic vitreoretinal surgery for non-infectious intermediate, posterior, and panuveitis; epiretinal membrane removal; fluocinolone acetonide sustained drug delivery; dexamethasone biodegradable intravitreal implants; and biopsy analysis.